Bausch Health US, LLC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$4.9Mgeneral payments (2019-2025)
$16Mresearch payments (2019-2025)
17,426clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Aplenzin $565K associated (2023-2025)
- Wellbutrin $238K associated (2023-2025)
- Targretin $1,244 associated (2023-2025)
- Siliq $970 associated (2023-2025)
- Jublia $39.07 associated (2023-2025)
- Arazlo $39.07 associated (2023-2025)
- Addyi $24.45 associated (2023-2025)
- Alden Multifocal $5.20 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Amy Wechsler | New York, NY | Dermatology | $2,359,940.67 |
| Andrew Von Eschenbach | Montgomery, TX | Urology | $814,372.78 |
| Andrew Blumenfeld | Carlsbad, CA | Neurology (Psychiatry & Neurology) | $84,227.52 |
| Joseph Pergolizzi | Naples, FL | Pain Medicine (Anesthesiology) | $40,460.00 |
| Donna Ryan | Baton Rouge, LA | Internal Medicine | $28,933.64 |
| Peter Kowey | Wynnewood, PA | Cardiovascular Disease | $17,150.00 |
| Steven Scrivani | Boston, MA | Oral and Maxillofacial Surgery | $15,000.00 |
| Anthony Auriemma | Westmont, IL | Family Medicine | $10,417.38 |
| Marcelo Kugelmas | Englewood, CO | Gastroenterology (Internal Medicine) | $10,416.58 |
| Joseph Martel | Rancho Cordova, CA | Ophthalmology | $10,400.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.